Page 48 - Technology Access Pool News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The next steps toward a ‘People’s Vaccine’ Jayati Ghosh May 10, 2021 23:35 Joe Biden tours a Pfizer manufacturing plant producing the COVID-19 vaccine in Kalamazoo, Michigan, U.S., Feb. 19, 2021. (Reuters) Short Url https://arab.news/z3b4r The Biden administration’s decision last week to stop opposing a proposed coronavirus disease (COVID-19) waiver of certain intellectual property rights under World Trade Organization rules is a welcome move. The Office of the US Trade Representative acknowledged that “the extraordinary circumstances of the COVID-19 pandemic call for extraordinary ...

Health Experts Say Expanding Vaccine Access Requires More Than Patent Waivers D.C. Health Nurse Manager Ashley Hennigan fills a syringe with a dose of the Johnson & Johnson coronavirus vaccine during a walk-up clinic at the John F. Kennedy Center for the Performing Arts' outdoor Reach area on May 6, 2021 in Washington, D.C. Chip Somodevilla / Getty Images Biolyse Pharma Corp., which makes injectable cancer drugs, was gearing up to start making generic biologic drugs, made from living organisms. Then the pandemic hit. Watching the covid death toll climb, the company decided its new production ...

The only way to end the COVID-19 pandemic is to immunize enough people worldwide. The slogan “no one is safe until we are all safe” captures the epidemiological reality we face. Outbreaks anywhere could spawn a SARS-CoV-2 variant that is resistant to vaccines, forcing us all back into some form of lockdown. Given the emergence of worrisome new mutations in India, Brazil, South Africa, the United Kingdom, and elsewhere, this is no mere theoretical threat. Worse, vaccine production is currently nowhere close to delivering the 10-15 billion doses needed to stop the spread of the virus. By th...

Date Time US support for waiving COVID vaccine intellectual property is a huge step Yesterday, the US Biden administration declared its support for waiving intellectual property rights, including patents, for COVID-19 vaccines. Author Associate Professor in Public Health, La Trobe University This decision represents a huge breakthrough in discussions at the World Trade Organisation (WTO) that have been deadlocked for more than six months. Other nations that have so far resisted pressure to support the waiver are likely to fall like dominoes in the wake of the US in coming days. Today, A...

Director-General's opening remarks at the media briefing on COVID-19 – 7 May 2021 Format Wednesday’s announcement by the United States of America that it will support a temporary waiver of intellectual property protections for COVID-19 vaccines is a significant statement of solidarity and support for vaccine equity. We are in an unprecedented crisis that requires unprecedented action. Cases are at a record high, almost 100 thousand people are dying globally each week, and we have a chronic vaccine crisis. This afternoon, WHO gave Emergency Use Listing to Sinopharm Beijing’s COVID-19 vac...